AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES

AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES

Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker, amlodipine, in patients with coronary artery disease. Results of randomized clinical trials PREVENT (2000), CAPARES (2000), CAMELOT (2004) and ENCORE II (2009) are analyzed.

Bibliographic Details
Main Author: Yu. M. Lopatin
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
coronary artery disease
calcium channel blockers
amlodipine
Online Access:https://www.rpcardio.com/jour/article/view/774

Internet

https://www.rpcardio.com/jour/article/view/774

Similar Items